This is a prescription for disaster. While all medications carry potential side effects, certain types have been shown to ...

Even after years of warnings, millions of older Americans with dementia are still being prescribed risky brain-altering drugs—often with no clear medical justification. Even after years of clinical ...

Dementia patients in the U.S. are still being prescribed risky CNS-active drugs despite safety warnings. New JAMA research ...

Two new groundbreaking drugs could slow the memory impairment, thinking skills and overall brain decline — and both are ...

Adverse side effects of recently approved Alzheimer’s therapy, lecanemab, are ‘manageable', reported a new study published in JAMA Neurology. The findings may inform discussions about the risks of ...

Eli Lilly's Alzheimer's treatment is approved for use in the U.S. but the European Medicines Agency recommended against the approval of the drug on Thursday. Indiana-based pharmaceutical company Eli ...

Years after doctors were warned to be cautious, many Americans with dementia continue to receive medications that can worsen ...

Alzheimer’s, the leading cause of dementia, affects some six million individuals nationwide, and 55 million worldwide. The disease, projected to impact 139 million people globally by 2050, can impair ...

An experimental Alzheimer's disease drug from Eisai (4523.T) and Biogen (BIIB.O) slowed cognitive decline in a closely watched trial but may carry a risk of dangerous side effects for certain patients ...

To learn more about the drug’s serious side effects, talk with your doctor or see donepezil’s prescribing information. The side effects of donepezil are generally the same regardless of age. But ...